Developer of immuno-diverse antibodies. The company develops immuno-diverse antibodies to fulfill the demand for efficacious antibody-based products in therapeutic, diagnostic and research applications.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 02-Mar-2016 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
JLABS | Accelerator/Incubator | 000 0000 | 000000 0 |